Blog

What is a .@US_FDA priority review voucher and how does it expand opportunity for #medicalresearch of #rarediseases?

The priority review voucher program incentivizes pharmaceutical companies to research drugs for very rare diseases. When a drug developer researches a rare disease, a voucher is received by that organization from the FDA to move [...]

October 27, 2017|Categories: General|

What kind of information can be gained from a mock clinical trial? How can this procedure help us learn about diversifying clinical trials?

Two populations in the United States - one in Altoona, Pennsylvania, the other in Atlanta, Georgia - of similar incomes, but different racial backgrounds, were enrolled in a mock clinical trial to gauge participation given [...]

October 24, 2017|Categories: General|

What information can the donation of one patient’s tumor yield about metastasis?

Michelle Monje, MD, PhD, is a researcher studying a rare type of pediatric brain tumor, Diffuse Intrinsic Pontine Glioma (DIPG). This type of cancer often spreads quickly and the patient dies only months after diagnosis. [...]

October 20, 2017|Categories: General|

What is the iMPACT Program and how will it bring diversity to clinical trials?

iMPACT is a three-year pilot program focusing on the recruitment and retention of minorities in cancer clinical trials. Its aim is to remove barriers and improve access to cancer-related clinical trials and is a partnership [...]

October 17, 2017|Categories: General|

How is it possible that a great many promising cancer drugs create a problem for research and trials? 

There are many new immunotherapeutic drugs for cancer in the research pipeline. Too few patients are available to fill the clinical trials,  as many are receiving treatment from physicians outside of the research institutions where [...]

October 13, 2017|Categories: General|

Research Ethics Education a critical priority for WCGF: New Grant Opportunities Offered.

In addition to its current grants to support travel, lodging and living expenses to enable research professionals from resource-poor countries to study research ethics and management, WCGF has expanded grant opportunities to include grants for [...]

October 11, 2017|Categories: General|

How are physicians and researchers working to make clinical trials more diverse?

The reasons minority participants avoid clinical trials are well documented. Historical lack of consent,  little diversity within the research team, and a percieved lack of relevance could all seem to push patients away. But researchers [...]

October 10, 2017|Categories: General|

What’s the procedure for getting access to an investigational drug in an emergency?

The Food & Drug Administration (FDA) has recently released a Manual of Policies and Procedures (MAPP) for the use of an investigational drug in an emergency - whether during or outside business hours. Because of [...]

October 6, 2017|Categories: General|

How does breast cancer differ between white and African American women?

Though the cells from breast cancer tumors of African American women and white women have an overwhelming number of similarities, aggressiveness of tumors and outcomes of the disease are drastically different. African American women are [...]

October 3, 2017|Categories: General|

How many types of cells are in the human body? Two hundred? More? A researcher found a new way to take a census of cells.

There are around 37 trillion cells in the human body. But those can be categorized into how many types? A simple Google search will yield a result of about 200, but some researchers, including Jay [...]

September 29, 2017|Categories: General|